UBS Group’s GlucoTrack GCTK Stock Holding History

UBS Group’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.26K	Buy	890 +843	+1,794%	+$7.93K	﹤0.01%	9071
2026 Q1	$456	Buy	47 +39	+488%	+$1.24K	﹤0.01%	9884
2025 Q4	$461	Buy	8 +5	+167%	+$445	﹤0.01%	9951
2025 Q3	$263	Buy	+3	New	+$271	﹤0.01%	9771
2025 Q2	–	Hold	0	–	–	–	10169
2025 Q1	–	Hold	0	–	–	–	10402
2024 Q4	–	Hold	0	–	-$7.43K	–	10094
2024 Q3	–	Hold	0	–	–	–	7908
2024 Q2	–	Hold	0	–	–	–	7607
2024 Q1	–	Hold	0	–	-$1.26K	–	9564
2023 Q4	–	Hold	0	–	–	–	8360
2023 Q3	–	Hold	0	–	–	–	9123
2023 Q2	–	Hold	0	–	–	–	8337
2022 Q1	–	Hold	0	–	-$3K	–	10472
2021 Q4	–	Hold	0	–	–	–	9655

Other funds holding GCTK

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

GIPW

Granite Islands Private Wealth Guilford, Connecticut $135M AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group's GCTK Position: Q2 2026 in Review

UBS Group increased its GlucoTrack (GCTK) stake by 1,794% in Q2 2026, buying an estimated $7.93K and bringing the position to 890 shares worth $4.26K. The position accounts for ﹤0.01% of the portfolio, ranked #9071.

UBS Group first reported a position in GCTK in Q3 2025 and has held it in 4 quarters since. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

UBS Group held 890 shares of GlucoTrack worth $4.26K as of Q2 2026.
UBS Group bought 843 GlucoTrack shares in Q2 2026, an estimated $7.93K.
GlucoTrack made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9071 holding.
UBS Group first reported a position in GlucoTrack in Q3 2025 and has held it in 4 quarters since.
18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.